Binding of the interleukin-2 (IL-2) to the IL-2 receptor (IL-2R) triggers a series of intracellular events culminating in lymphocyte proliferation and differentiation. We report here the identification of a novel G245R polymorphism in the membrane proximal domain of the IL-2 receptor b chain (IL-2Rb). Present at a frequency of 7.2%, the IL-2-Rb G245R was identified in a population of Eastern Sudan exposed to a severe outbreak of visceral leishmaniasis (VL), a disease associated with a marked depression of T-cell antigen-specific responses. The location of the G245R polymorphism next to the box1/box2 proximal cytokine receptor homology segment and suggestive genetic association with the development of disease (P ¼ 0.043), suggest that it may affect Janus kinase (JAK) association and impair growth signal transduction. However, additional genetic association with a synonymous single nucleotide polymorphism (IL2RB þ 8777T) suggests that other variations of IL2RB or nearby genes participate in the highly significant linkage with VL at 22q12 previously reported for this population.
Introduction
The Interleukin-2 (IL-2)/IL-2 receptor (IL-2R) system plays a central role in the regulation of the magnitude and duration of the T-cell immune response following antigen encounter.
1,2 Dysregulated IL-2 signalling has been postulated to play a pathogenic role in a number of T-cell-mediated diseases leading to the development of therapeutic strategies aimed at modulating IL-2 signal strength: IL-2 itself is infused in patients with cancer or AIDS to enhance T-cell numbers and function; 3, 4 conversely, anticytokine agents that block IL-2 and/or its receptor are used to inhibit T-cell responses in transplanted patients 5 or rheumatoid arthritis. 6 IL-2 mediates its complex biological functions by binding to its specific receptor consisting of three subunits: IL-2Ra, IL-2Rb and IL-2Rg. The highly inducible a-chain has a very short cytoplasmic domain and functions to increase the affinity for IL-2. In contrast, IL-2R b-and g-chain have longer cytoplasmic domains that participate in signal transduction. Despite an absolute requirement for the g-chain in signalling, the majority of known signalling pathways physically link to the receptor via IL-2Rb, generally through phosphorylated cytoplasmic residues. 7 Stimulation of lymphocytes with IL-2 results in the rapid activation of the receptor-associated tyrosine kinases JAK1 and JAK3. 8, 9 Activated JAKs are critical for inducing tyrosine phosphorylation of downstream substrates including signal transducer and activator of transcription 5, which then translocates to the nucleus to regulate target gene transcription and cellular proliferation. 10 Leishmania species are obligate intracellular protozoan parasites of macrophages. Parasitism of the human host by Leishmania is asymptomatic in most cases, whereas, depending on host-parasite complex interactions, some individuals develop diseases of diverse severity. Leishmaniasis is well known as a T-cell-mediated disease. Studies in the mice experimental models have demonstrated that a Th1 response is associated with the control of infection by Leishmania major, whereas a Th2 response is associated with disease progression. 11 However, in human visceral leishmaniasis (VL) caused by parasites of the Leishmania donovani complex, such a dichotomy of the T-cell-specific response is less clear. The acute phase of disease is rather associated with a marked depression of T-cell responses, which has been characterized by impaired cell proliferation 12 and absence of IL-2 production by lymphocytes on in vitro stimulation with Leishmania antigens. 13 Noteworthy, this suppression can be reversed in vitro, both in mice 14 and human, 15 by the addition of IL-2, thus suggesting that the T-cell anergic state is in part mediated by a defect in IL-2/IL-2R signalling. 16 Interestingly, the IL2RB gene coding the IL2Rb-chain is located on chromosome 22q12 in a region for which we found a highly significant genetic linkage by a genome-wide linkage study of VL susceptibility in multicase families of Eastern Sudan 17 affected by a severe outbreak of VL (1996) (1997) (1998) (1999) (2000) . 18, 19 This prompts us to investigate whether genetic polymorphisms of the IL2RB gene were associated with resistance/susceptibility to VL in this population. We report here the identification of a new sequence variant G245R in the cytoplasmic b-chain proximal membrane domain that displayed suggestive genetic association with VL. The potential functional role of this polymorphism in mediating signal transduction and its relevance in controlling the development of VL are discussed.
Results and discussion

Screening of IL2RB variants
We analysed global genetic variation in IL2RB by direct re-sequencing of the 5 0 promoter region, exons and intron-exon boundaries and 3 0 UTR of the gene for seven subjects. Five were VL-affected children chosen in the families with highest LOD score at 22q12, and two were healthy controls, whom although exposed to Leishmania infection, did not develop the disease throughout the outbreak. In all, 21 single nucleotide polymorphisms (SNPs) were identified ( Figure 1 ). Seven SNPs are newly described polymorphisms of IL2RB among which two are non-synonymous SNPs (L10V and G245R). Of the 21 identified SNPs, 14 are located in introns; three in the 3 0 UTR and four in the coding sequence of the gene. Interestingly, no SNPs were identified in the 5 0 and exon 1 regulatory sequence of the gene. One coding sequence SNP was synonymous ( þ 8777 C4T, exon 8) and three were non-synonymous SNPs. The þ 28 G4C SNP in exon 2 encodes a L10V amino-acid change in the signal peptide of the protein; the þ 1705 C4T SNP in exon 4 encodes a S57F polymorphism in the extracellular domain of the protein and the þ 8838 G4A SNP in exon 8 encodes a non-conservative amino-acid change G245R introducing a positive charge in the membraneproximal region (prox domain) of the cytoplasmic tail. Interestingly, the IL-2-Rb prox domain plays a critical role in the induction of cellular proliferation by mediating JAK1 and JAK3 interaction with IL-2R. In vitro mutational analysis of the prox domain 20, 21 has enabled the identification of several discontinuous amino-acid residues and protein segments critical for efficient signal transduction. Noteworthy, the G245R lies just next to the box 1/box 2 proximal cytokine receptor homology Figure 1 ). Deletions or mutations in box 1 or box 2 regions of IL-2Rb were found to both impair cellular proliferation 22 and JAK1 and JAK3 binding.
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Genetic association with VL In order to test genetic association with the risk of developing VL, 7 SNPs spanning the IL2RB gene were genotyped on the whole set of 59 nuclear families (270 individuals) that were used to map a major susceptibility locus on chromosome 22q12. 17 All non-synonymous variants were included in this analysis as well as four non-coding SNPs for which the minor allele was at least observed on three of the 14 sequenced chromosomes. All SNPs were in Hardy-Weinberg equilibrium in our population. Genetic association of these SNPs with VL was assessed by a Family Based Association Test (FBAT v1.5.5; http://www.biostat.harvard.edu/~fbat/default.html), which enables testing for genetic association in multicase families in the presence of linkage 26 by means of a transmission disequilibrium test. 27 Results are presented in Table 1 . Under an additive model, significant associations were observed between the two exon 8 SNPs and VL. Associations remained significant when using the empirical variance-covariance estimator, 28 which is required when sibling marker genotypes are correlated (e.g. when there is linkage and the analysis includes multiplex families). Similar results were obtained for these two SNPs under a dominant model of transmission (P ¼ 0.016 and P ¼ 0.041 for IL2RB þ 8777T and IL2RB þ 8838A, respectively). Haplotype analysis of the seven genotyped IL2RB SNPs did not show any significant association with VL (data not shown).
Interestingly, the two exon 8 SNPs associated with VL, although close to each other (61 bp) are in poor linkage disequilibrium (r 2 ¼ 0.045), furthermore, whereas þ 8777T is associated with protection against VL (P ¼ 0.026), þ 8838A is associated with an increased risk of developing VL (P ¼ 0.043). Thus, this argues that these two IL2RB polymorphisms carry independent effects on VL resistance/susceptibility. The þ 8777C/T polymorphism is synonymous and has probably no functional effects and is rather in linkage disequilibrium with another causal SNP located in the IL2RB unsequenced regions or a nearby gene. The fact that the IL2RB þ 8838A/G encodes a non-conservative amino-acid change G245R in a region of the b-chain involved in the early events of IL-2 signalling is consistent with a potential functional role of this SNP. The positive charge brought by R245 could indeed both affect hetero-dimerization of the b-and g-chain upon IL-2 recognition and/or induce conformational changes in the IL-2Rb prox domain affecting JAK kinases association/activation. Among other signalling pathways that link to the b-chain cytoplasmic tail, JAK kinases are involved in IL-2-induced cellular proliferation. Thus, the G245R polymorphism identified in this Sudanese population could provide a clue to explain the anergic state of the CD4 þ subset during the acute phase of disease. 12, 13 However, one should note that the IL-2Rb chain is constitutively expressed on other cell types than T lymphocytes and participates in the activation and differentiation of NK cells 29 and monocytes, 30 which indubitably also play a critical role in the control of Leishmania infections.
The genetic association observed between the G245R polymorphism and the risk of VL is borderline Genetic association of selected IL2RB SNPs with VL was assessed by mean of a transmission disequilibrium test using the FBAT v5.1.1, which enables to test for association in the presence of linkage by use of an empirical variance-covariance estimator. Results presented were obtained under an additive model of transmission. The family set used for this study has been described elsewhere. 17 It was composed of 59 nuclear families comprising 2-5 affected sibs and parents. Primer sequences and genotyping conditions for the SNPs are available upon request. The FBAT-e (empirical variance-covariance estimator) function was used to test for genetic association in the presence of linkage.
IL2RB and human visceral leishmaniasis B Bucheton et al significant. The sample size used in the frame of this study, composed of 59 nuclear families with multiple affected children (159) did not have sufficient power to detect genetic association with low frequency SNPs. The IL2RB þ 8838A allele is only present at 7.2% in our study population and only 10 families were informative in the analysis. Association of IL-2-Rb G245R with VL thus requires further confirmation on larger sample size. Furthermore, given its low frequency and associated P-value, this polymorphism alone is unlikely to explain either the high burden of cases that occurred in this village population during the outbreak (in which more than 25% developed VL) or the highly significant LOD score observed at 22q12 (LOD ¼ 3.5; P ¼ 0.00003). 17 Our results indeed suggest that other polymorphisms of this genetic region, possibly in linkage disequilibrium with the IL2RB þ 8777C/T synonymous SNP, may also have independent effects on the risk of VL. Further work is required to test if the linkage with VL observed on chromosome 22 is due to a major gene or rather to genetic variations in multiple genes of the region. Indeed, the locus identified on chromosome 22q12 is large (8-10 cM) and encompasses many other genes, which could be implicated in determining VL susceptibility. Among those are for example, CSF2RB (granulocyte-macrophage-colony-stimulating factor receptor bchain), NCF4 (p40 PHOX), XBP-1 (X box-binding protein 1) or LIF (leukaemia inhibitory factor). Linkage disequilibrium mapping in 22q12 is now required to narrow down (or split) the susceptibility locus interval in order to choose positional candidate for the analysis of the VL resistance/susceptibility phenotype.
In conclusion, we have identified a novel polymorphism encoding a non-conservative amino-acid change in the proximal membrane cytoplasmic domain of the IL2Rb-chain. Location of the G245R polymorphism in a protein domain implicated in signal transduction and genetic association with VL suggest that this polymorphism may have a functional effect on IL-2-mediated signalling. Whereas this needs to be confirmed by in vitro functional studies, we believe that this polymorphism is worth testing in other populations (especially those of African descent) affected by VL or other T-cellmediated disease. It could also provide an interesting marker for the analysis of IL-2 responsiveness in patients receiving IL-2 immunotherapy.
